Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Income Statement

MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Income Statement History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
INCOME :
Gross Sales ₹14,936 Cr₹12,678 Cr₹10,677 Cr₹9,106 Cr₹8,071 Cr
     Sales ₹659 Cr₹471 Cr₹10,607 Cr₹9,048 Cr₹8,067 Cr
     Job Work/ Contract Receipts ₹28 Cr₹45 Cr₹21 Cr₹34 Cr-
     Processing Charges / Service Income ₹14,249 Cr₹12,162 Cr₹49 Cr₹23 Cr₹3.46 Cr
     Revenue from property development -----
     Other Operational Income -----
Less: Excise Duty -----
Net Sales ₹14,278 Cr₹12,207 Cr₹10,260 Cr₹8,749 Cr₹7,782 Cr
EXPENDITURE :
Increase/Decrease in Stock ₹36 Cr₹-183 Cr₹-54 Cr₹291 Cr₹-450 Cr
Raw Material Consumed ₹4,016 Cr₹3,672 Cr₹3,252 Cr₹2,623 Cr₹2,871 Cr
     Opening Raw Materials ₹552 Cr₹409 Cr₹414 Cr₹399 Cr₹284 Cr
     Purchases Raw Materials ₹2,365 Cr₹2,160 Cr₹1,837 Cr₹1,829 Cr₹2,173 Cr
     Closing Raw Materials ₹629 Cr₹552 Cr₹409 Cr₹414 Cr₹399 Cr
     Other Direct Purchases / Brought in cost ₹1,728 Cr₹1,656 Cr₹1,410 Cr₹809 Cr₹814 Cr
     Other raw material cost -----
Power & Fuel Cost ₹184 Cr₹149 Cr₹125 Cr₹109 Cr₹103 Cr
     Electricity & Power ₹184 Cr₹149 Cr₹125 Cr₹109 Cr₹103 Cr
     Oil, Fuel & Natural gas -----
     Coals etc -----
     Other power & fuel -----
Employee Cost ₹3,184 Cr₹2,692 Cr₹2,261 Cr₹1,918 Cr₹1,621 Cr
     Salaries, Wages & Bonus ₹2,930 Cr₹2,488 Cr₹2,094 Cr₹1,788 Cr₹1,515 Cr
     Contributions to EPF & Pension Funds ₹137 Cr₹118 Cr₹100 Cr₹89 Cr₹74 Cr
     Workmen and Staff Welfare Expenses ₹51 Cr₹29 Cr₹19 Cr₹22 Cr₹15 Cr
     Other Employees Cost ₹66 Cr₹58 Cr₹47 Cr₹20 Cr₹17 Cr
Other Manufacturing Expenses ₹337 Cr₹216 Cr₹173 Cr₹151 Cr₹160 Cr
     Sub-contracted / Out sourced services -----
     Processing Charges -----
     Repairs and Maintenance ₹72 Cr₹56 Cr₹43 Cr₹39 Cr₹37 Cr
     Packing Material Consumed -----
     Other Mfg Exp ₹265 Cr₹161 Cr₹130 Cr₹112 Cr₹124 Cr
General and Administration Expenses ₹1,424 Cr₹1,314 Cr₹939 Cr₹1,001 Cr₹656 Cr
     Rent , Rates & Taxes ₹156 Cr₹134 Cr₹89 Cr₹132 Cr₹84 Cr
     Insurance ₹31 Cr₹26 Cr₹18 Cr₹15 Cr₹14 Cr
     Printing and stationery ₹11 Cr₹11 Cr₹9.50 Cr₹10 Cr₹7.02 Cr
     Professional and legal fees ₹389 Cr₹378 Cr₹203 Cr₹169 Cr₹88 Cr
     Traveling and conveyance ₹522 Cr₹461 Cr₹378 Cr₹496 Cr₹358 Cr
     Other Administration ₹315 Cr₹304 Cr₹242 Cr₹178 Cr₹105 Cr
Selling and Distribution Expenses ₹1,325 Cr₹1,165 Cr₹924 Cr₹638 Cr₹708 Cr
     Advertisement & Sales Promotion ₹798 Cr₹755 Cr₹601 Cr₹374 Cr₹452 Cr
     Sales Commissions & Incentives ₹283 Cr₹233 Cr₹198 Cr₹180 Cr₹174 Cr
     Freight and Forwarding ₹244 Cr₹176 Cr₹125 Cr₹84 Cr₹82 Cr
     Handling and Clearing Charges -----
     Other Selling Expenses -₹0.32 Cr₹0.15 Cr₹0.28 Cr₹0.22 Cr
Miscellaneous Expenses ₹149 Cr₹161 Cr₹125 Cr₹117 Cr₹121 Cr
     Bad debts /advances written off ₹10.00 Cr₹5.00 Cr₹4.62 Cr₹4.64 Cr₹4.92 Cr
     Provision for doubtful debts ₹10 Cr₹8.61 Cr₹7.96 Cr₹9.15 Cr₹9.65 Cr
     Losson disposal of fixed assets(net) ₹2.31 Cr₹5.37 Cr--₹3.74 Cr
     Losson foreign exchange fluctuations -----
     Losson sale of non-trade current investments -----
     Other Miscellaneous Expenses ₹127 Cr₹142 Cr₹112 Cr₹103 Cr₹103 Cr
Less: Expenses Capitalised -----
Total Expenditure ₹10,655 Cr₹9,187 Cr₹7,745 Cr₹6,848 Cr₹5,791 Cr
Operating Profit (Excl OI) ₹3,622 Cr₹3,020 Cr₹2,515 Cr₹1,902 Cr₹1,991 Cr
Other Income ₹359 Cr₹537 Cr₹280 Cr₹129 Cr₹196 Cr
     Interest Received ₹58 Cr₹68 Cr₹40 Cr₹13 Cr₹13 Cr
     Dividend Received ---₹0.00 Cr₹0.00 Cr
     Profit on sale of Fixed Assets -₹2.76 Cr₹0.48 Cr₹1.67 Cr-
     Profits on sale of Investments -₹164 Cr---
     Provision Written Back ₹7.48 Cr₹0.81 Cr₹2.48 Cr₹4.15 Cr₹34 Cr
     Foreign Exchange Gains ₹70 Cr₹20 Cr₹8.44 Cr₹10 Cr₹8.85 Cr
     Others ₹223 Cr₹282 Cr₹229 Cr₹100 Cr₹140 Cr
Operating Profit ₹3,981 Cr₹3,557 Cr₹2,795 Cr₹2,030 Cr₹2,187 Cr
Interest ₹644 Cr₹432 Cr₹34 Cr₹46 Cr₹60 Cr
     InterestonDebenture / Bonds -----
     Interest on Term Loan ₹621 Cr₹395 Cr₹19 Cr₹36 Cr₹16 Cr
     Intereston Fixed deposits -----
     Bank Charges etc ₹11 Cr₹11 Cr₹6.42 Cr₹1.30 Cr₹4.02 Cr
     Other Interest ₹12 Cr₹25 Cr₹8.71 Cr₹8.42 Cr₹40 Cr
PBDT ₹3,337 Cr₹3,125 Cr₹2,761 Cr₹1,985 Cr₹2,127 Cr
Depreciation ₹886 Cr₹621 Cr₹378 Cr₹326 Cr₹167 Cr
Profit Before Taxation & Exceptional Items ₹2,451 Cr₹2,504 Cr₹2,383 Cr₹1,659 Cr₹1,960 Cr
Exceptional Income / Expenses ₹-130 Cr----
Profit Before Tax ₹2,333 Cr₹2,516 Cr₹2,398 Cr₹1,671 Cr₹1,975 Cr
Provision for Tax ₹395 Cr₹510 Cr₹457 Cr₹362 Cr₹522 Cr
     Current Income Tax ₹539 Cr₹529 Cr₹495 Cr₹332 Cr₹451 Cr
     Deferred Tax ₹-161 Cr₹-64 Cr₹-31 Cr₹41 Cr₹49 Cr
     Other taxes ₹16 Cr₹45 Cr₹-7.22 Cr₹-12 Cr₹21 Cr
Profit After Tax ₹1,938 Cr₹2,007 Cr₹1,941 Cr₹1,310 Cr₹1,453 Cr
Extra items -₹4.53 Cr₹0.98 Cr--
Minority Interest ₹-25 Cr₹-20 Cr₹-29 Cr₹-28 Cr₹-19 Cr
Share of Associate -----
Other Consolidated Items -----
Consolidated Net Profit ₹1,913 Cr₹1,991 Cr₹1,913 Cr₹1,282 Cr₹1,433 Cr
Adjustments to PAT -----
Profit Balance B/F ₹11,907 Cr₹9,919 Cr₹8,012 Cr₹6,735 Cr₹5,304 Cr
Appropriations ₹13,820 Cr₹11,910 Cr₹9,925 Cr₹8,017 Cr₹6,737 Cr
     General Reserves -----
     Proposed Equity Dividend -----
     Corporate dividend tax -----
     Other Appropriation ₹16 Cr₹2.47 Cr₹6.27 Cr₹4.85 Cr₹1.80 Cr
Equity Dividend % -----
Earnings Per Share ₹46.34₹48.25₹47.75₹32.00₹35.78
Adjusted EPS ₹46.34₹48.25₹47.75₹32.00₹35.78

Compare Income Statement of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹105,174.6 Cr 0.6% 7% 4.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹468,458.0 Cr 0.7% 8.1% 16% Stock Analytics
DIVIS LABORATORIES ₹193,383.0 Cr 7% 10.2% 3.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹169,829.0 Cr 2.5% 11.3% 49.6% Stock Analytics
CIPLA ₹116,164.0 Cr -0.3% 4.1% -3.3% Stock Analytics
DR REDDYS LABORATORIES ₹102,648.0 Cr -3.2% -3.9% -3% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

0.6%

7%

4.1%

SENSEX

0.9%

2.2%

-7.5%


You may also like the below Video Courses